Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Streptococcal superantigens.

Thomas Proft1, John D Fraser

  • 1Department of Molecular Medicine and Pathology, School of Medicine, University of Auckland, Auckland, New Zealand.

Chemical Immunology and Allergy
|March 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Group A Streptococcal Virulence Factors and Vaccine Development-An Update.

Microorganisms·2026
Same author

Progress in peptide and protein therapeutics: Challenges and strategies.

Acta pharmaceutica Sinica. B·2026
Same author

Refinement of a novel staphylococcal superantigen-like poly protein vaccine.

Vaccine·2025
Same author

The Emergence and Impact of the M1<sub>UK</sub> Lineage on Invasive Group A Streptococcus Disease in Aotearoa New Zealand.

Open forum infectious diseases·2024
Same author

Recombinational exchange of M-fibril and T-pilus genes generates extensive cell surface diversity in the global group A <i>Streptococcus</i> population.

mBio·2024
Same author

Feasibility of using a combination of staphylococcal superantigen-like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureus.

Immunology and cell biology·2024

Superantigens (SAgs) are potent immune activators produced by bacteria like Streptococcus pyogenes. Understanding their structure and interaction with host cells is crucial for combating severe diseases such as toxic shock syndrome.

Area of Science:

  • Immunology
  • Microbiology
  • Structural Biology

Background:

  • Superantigens (SAgs) are potent immune activators that bind to major histocompatibility complex (MHC) class II and T cell receptor molecules.
  • Streptococcus pyogenes (group A streptococcus, GAS) is a primary producer of SAgs.
  • Novel SAgs have been identified through genome projects, with orthologues found in other Streptococcus species.

Purpose of the Study:

  • To review the structural and functional characteristics of streptococcal SAgs.
  • To elucidate the molecular interactions between SAgs, MHC class II, and T cell receptors.
  • To discuss the role of SAgs in severe GAS infections, including streptococcal toxic shock syndrome.

Main Methods:

  • Database mining of GAS genome projects to identify novel SAgs.

Related Experiment Videos

  • Crystal structure analysis of streptococcal SAgs.
  • Cocrystal structure analysis of SAgs complexed with MHC class II and T cell receptor Beta-chains.

    • Main Results:

    • Identification of numerous novel streptococcal SAgs.
    • Determination of a common protein fold among analyzed streptococcal SAgs.
    • Detailed insights into the molecular interactions of SAgs with host cell receptors.

    Conclusions:

    • Streptococcal SAgs share conserved structural features and molecular interaction mechanisms.
    • SAgs are implicated in severe GAS diseases, notably streptococcal toxic shock syndrome.
    • Further research into SAgs is vital for understanding and treating invasive streptococcal infections.